1. Kurita-Taniguchi, M., A. Fukui, K. Hazeki, A. Hirano, S. Tsuji, M. Watanabe, M. Matsumoto, S. Ueda, and T. Seya. 2000. Activation of human macrophages through CD46 (measles virus receptor): Production of IL-12 p40 and nitric oxide in association with recruitment of SHP-1 to CD46.J. Immunol.165: 5143-5152.
  2. Tsuji, S., M. Matsumoto, O. Takeuchi, S. Akira, I. Azuma, A. Hayashi, K. Toyoshima, and T. Seya. 2000. Maturation of human human dendritic cells by cell-wall skeleton of Mycobacterium bovis Bacillus Calmette-Guerin: involvement of Toll-like receptors.Infect. Immun.68: 6883-6890.
  3. Kikkawa, S., M. Matsumoto, T. Sasaki, M. Nishiguchi, K. Tanaka, K. Toyoshima, and T. Seya. 2000. Complement activation on Mycoplasma fermentans induced mycoplasma clearance from infected cells: Probing the organism with mAbs against M161Ag.Infect. Immun.68: 1672-1680.
  4. Nomura, M., A. Tsujimura, N. A. Begum, M. Matsumoto, K. Toyoshima, and T. Seya. 2000. Mechanism of gene regulation of membrane cofactor protein (CD46) in mice: Identification and characterization of a silencer regulatory element in the 3'-flanking region of the murine CD46 gene.Biochem. J.351: 353-365.
  5. Shoji, T., I. Nakanishi, K. Kunitou, Y. Tsubakihara, Y. Hirooka, Y. Kishi, M. Hatanaka, M. Matsumoto, K. Toyoshima, and T. Seya. 2000. Determination of human urinary CD46 (membrane cofactor protein) with antibody-coated paramagnetic beads: Urine secretory CD46 levels are increased in patients with glomerular diseases.Clin. Immunol.95: 163-169.
  6. Kikkawa, S., K. Shida, M. Matsumoto, H. Okamura, S. Tsuji, M. Nomura, N. A. Begum, Y. Suzuki, K. Toyoshima, and T. Seya. 2000. A comparative analysis of the antigenic, structural and functional properties of three different preparations of recombinant human IL-18.J. Interferon Cytokine Res.20: 179-185.
  7. Begum N. A., Y. Murakami, S. Mikata, M. Matsumoto, H. Hatanaka, S. Nagasawa, T. Kinoshita, and T. Seya. 2000. Molecular remodeling of human CD46 for xenotransplantation: designing a potent complement regulator without measles virus receptor activity.Immunology100: 131-139.
  8. Saeki, Y., O. Hazeki, K. Hazeki, M. Ui, M. Matsumoto, K. Toyoshima, H. Akedo, and T. Seya. 2000. Participation of a MEK-independent pathway of MAP kinase activation in modulation of cell growth of mouse hepatoma cell lines.Int. J. Molec. Med.6: 155-160.
  9. Saeki, Y., K. Hazeki, H. Akedo., and T. Seya. 2000. Correlation between metastatic potency and the down-regulation of E-cadherin in the mouse hepatoma cell lines, G-1 and G-5.Oncol. Rep.7: 731-735.